Psyllid ID: psy9363


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-
MDSRVSNAGKTHDEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLNKEGHYRP
ccccccccccccHHHHHccccccEEEccccccccHHHHHHHHHccccccEEEccccccccccccccccccEEEEccccccccccccccccccccccccccEEEEEccccccccccccccHHHHHHccccccccccccccccccccccHHHHcccccHHHHHHHHHHHcccccccccccEEEEccccccccccccccEEEEEEEEEcccccEEEEEEEccccccccccEEccEEEEEEcccccEEEEEcccccccHHHHHHHHHHHccccHHHHHHHHHHHHHHHccccEEEEccccHHHHHccccccccccccccccccccccccEEEEEcccccccHHHHHHHHccccccEEEccccccccccccccccccccEEEccccccccHHHHHHHcccccccEEEccccccccccccccccccc
cccEEEcccccHHHHHHHccccEEEEccccccccHHHHHHHHHHcccccEEEEEccccccccccccccccccHHHHHHHcEccccccHHHHHHHHHHcHHHccccccccccccccHHHHHHHHHHHHHHHHHccccccHHHHccHHHHHHHHHHHHHHHcccHHHHHHHcccccccccEcccHccccEEEEEcccEEEEEEEEcccccccEEEEEEEcccccccccccEccEEEEEEEccccccEEccccccccccHHHHHHHHccccccccccHHHccEEEEEccccEEEEEcHHHHHHHHHHHHHcccccccccHHHcccccEEEEccHHHHHHcHHHHHHHHHHccccEEEcccccEEcccccccHHcccEEEEEcccccccHHHHHHHHHcccHHEEEccccccccccccccccccc
mdsrvsnagkthdEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIrlksssapahsYLAEVVFFVHLgrtlcdedfvkegsllhylpklsslrftknpilaeERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFleanprvgdnyFQVMeddiglrvcdseghrgtiryvgsvegtqgvwygidwdsetrgkhdgshngvkYFWThsttsgsfmrrdklnfgSSFMEALHRKYvetdneltVRENVEEVKAsinapflelvgfdqvheeqntnklpipndtsgvmeqifpqghihtltlgnMGYIWADILKLLANFpvtclklpsnrittldsvpgmFSSLEELYLqennivdwgevnalgslpnlkylnLASTNlrniklnkeghyrp
mdsrvsnagkthdeieqavPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHylpklsslrftknpilaeervvssrektiarlgglkllngsaierqerqgseydYIKEFGAVWLDEKRRAEFleanprvgdnyFQVMEDDIGLRVCDSeghrgtiryvgsvegtqGVWYGIDWDSETRgkhdgshngVKYFWThsttsgsfMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLnlastnlrniklnkeghyrp
MDSRVSNAGKTHDEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLNKEGHYRP
****************QAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAI******GSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVH**************SGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIK*********
************DEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYV***********************LELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKL********
***********HDEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLNKEGHYRP
***RVSNAGKTHDEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLNKE*****
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MDSRVSNAGKTHDEIEQAVPFIEDLDLSRNLLASWFAVGEITCQLKHLRHLNLRIRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPKLSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYFQVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPVTCLKLPSNRITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLNKEGHYRP
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query421 2.2.26 [Sep-21-2011]
Q5U378 521 Tubulin-specific chaperon yes N/A 0.539 0.435 0.305 2e-24
Q15813 527 Tubulin-specific chaperon yes N/A 0.548 0.438 0.267 8e-23
Q5RBD9 527 Tubulin-specific chaperon yes N/A 0.503 0.402 0.314 2e-21
Q55CN0 525 Tubulin-specific chaperon yes N/A 0.532 0.426 0.310 5e-21
Q5U508 522 Tubulin-specific chaperon N/A N/A 0.496 0.400 0.337 7e-21
Q8CIV8 524 Tubulin-specific chaperon yes N/A 0.517 0.416 0.296 2e-20
Q5FVQ9 524 Tubulin-specific chaperon yes N/A 0.517 0.416 0.292 8e-20
Q32KS0 528 Tubulin-specific chaperon yes N/A 0.515 0.410 0.327 6e-18
P39937 518 Protein PAC2 OS=Saccharom yes N/A 0.232 0.189 0.306 3e-07
P35458 1224 Dynactin subunit 1 OS=Gal no N/A 0.159 0.054 0.4 7e-06
>sp|Q5U378|TBCE_DANRE Tubulin-specific chaperone E OS=Danio rerio GN=tbce PE=2 SV=2 Back     alignment and function desciption
 Score =  114 bits (284), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 132/295 (44%), Gaps = 68/295 (23%)

Query: 180 VMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHS 239
           ++++ +G RVC  +G RGT+RYVG V  T GVW G++WD   RGKHDGSH+GV+YF    
Sbjct: 2   MLDEAVGRRVC-CDGERGTVRYVGPVPPTAGVWLGVEWDHPERGKHDGSHDGVRYFTCRH 60

Query: 240 TTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVH 299
            T GSF+R  K +FG  ++ AL ++Y     E+T     EE+K  I++  + +VGF+ V 
Sbjct: 61  PTGGSFVRPQKASFGVDYVTALKQRYEVEIEEVT----AEEMK--ISSKTVVMVGFENVK 114

Query: 300 EEQNTNKL------------PIPN-------------DTSG-----------VMEQIFPQ 323
           ++Q+   L            P P              D SG           + EQ+   
Sbjct: 115 KKQSVKNLTEVGLRRCEVSAPGPENEIRNTTPFVQSLDLSGNLLSSWEVLAAITEQLDSL 174

Query: 324 GHIH-----------------------TLTLGNMGYIWADILKLLANF-PVTCLKLPSNR 359
             +H                        L++ +    W  +L     +  V  L L  N 
Sbjct: 175 QELHLSHNRLSISSAPSSLSSAFSHLRVLSINSCALTWTQVLHCAPMWQQVEELYLADNN 234

Query: 360 ITTLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLN 414
           IT L     +  +L  L L  N I     V  +  LP L+ LNL+ST+L  IK +
Sbjct: 235 ITELLRPEHVLQALTVLDLSNNQIAQ-ETVLEISHLPRLERLNLSSTSLSEIKFS 288




Tubulin-folding protein; involved in the second step of the tubulin folding pathway.
Danio rerio (taxid: 7955)
>sp|Q15813|TBCE_HUMAN Tubulin-specific chaperone E OS=Homo sapiens GN=TBCE PE=1 SV=1 Back     alignment and function description
>sp|Q5RBD9|TBCE_PONAB Tubulin-specific chaperone E OS=Pongo abelii GN=TBCE PE=2 SV=1 Back     alignment and function description
>sp|Q55CN0|TBCE_DICDI Tubulin-specific chaperone E OS=Dictyostelium discoideum GN=tbce PE=3 SV=1 Back     alignment and function description
>sp|Q5U508|TBCE_XENLA Tubulin-specific chaperone E OS=Xenopus laevis GN=tbce PE=2 SV=1 Back     alignment and function description
>sp|Q8CIV8|TBCE_MOUSE Tubulin-specific chaperone E OS=Mus musculus GN=Tbce PE=1 SV=1 Back     alignment and function description
>sp|Q5FVQ9|TBCE_RAT Tubulin-specific chaperone E OS=Rattus norvegicus GN=Tbce PE=2 SV=1 Back     alignment and function description
>sp|Q32KS0|TBCE_BOVIN Tubulin-specific chaperone E OS=Bos taurus GN=TBCE PE=2 SV=1 Back     alignment and function description
>sp|P39937|PAC2_YEAST Protein PAC2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=PAC2 PE=1 SV=1 Back     alignment and function description
>sp|P35458|DCTN1_CHICK Dynactin subunit 1 OS=Gallus gallus GN=DCTN1 PE=2 SV=2 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query421
156544686 525 PREDICTED: tubulin-specific chaperone E- 0.536 0.430 0.358 3e-29
91079236517 PREDICTED: similar to beta-tubulin cofac 0.541 0.441 0.314 4e-29
119590429464 tubulin-specific chaperone e, isoform CR 0.534 0.484 0.323 1e-27
326429505354 hypothetical protein PTSG_06731 [Salping 0.498 0.593 0.331 1e-26
383850534 527 PREDICTED: tubulin-specific chaperone E- 0.529 0.423 0.332 2e-26
77748012306 Zgc:123075 [Danio rerio] 0.539 0.741 0.347 3e-26
307182233 705 Tubulin-specific chaperone E [Camponotus 0.524 0.313 0.327 5e-26
307210248 527 Tubulin-specific chaperone E [Harpegnath 0.527 0.421 0.342 8e-26
332026204432 Tubulin-specific chaperone E [Acromyrmex 0.494 0.481 0.358 2e-25
350400723 746 PREDICTED: tubulin-specific chaperone E- 0.522 0.294 0.326 7e-25
>gi|156544686|ref|XP_001605321.1| PREDICTED: tubulin-specific chaperone E-like [Nasonia vitripennis] Back     alignment and taxonomy information
 Score =  135 bits (341), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 146/296 (49%), Gaps = 70/296 (23%)

Query: 185 IGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGS 244
           IG RV D EGH GT++YVG+V  T+G W GIDWD  +RGKH+G++ G+KYF T   TSGS
Sbjct: 8   IGCRV-DCEGHIGTVKYVGTVGNTKGQWLGIDWDDPSRGKHNGTYEGLKYFETWHPTSGS 66

Query: 245 FMRRDKLNFGSSFMEALHRKYVETDNELT--VRENVEEVKASINAPFLELVGFDQVHEEQ 302
           F+R  K NFG S  EA+  +Y   D+EL    R+++  V+ SINAPF+E+VGF +V+++Q
Sbjct: 67  FIRPGKANFGISCPEAIKVRYGYIDDELAGIDRDSIASVQKSINAPFVEMVGFSKVNKKQ 126

Query: 303 NT-NKLPI-------------PNDTSGVMEQIFPQGHIHTLTLGNMGYIWADI---LKLL 345
           +  ++L I             P + + +   I      H L   N   + A+I   L++L
Sbjct: 127 SKFDQLKIVCMQAQCISSAGYPGELAALCSMIEELDLSHNLI--NSWKVVAEICTELQIL 184

Query: 346 AN--------------------FPV-----------------TCLK-LPS--------NR 359
                                 FPV                  CLK  PS        N 
Sbjct: 185 QQLNVSDNHLPVENGMEIYAHAFPVLRHLTMGRMKYDWPAVMQCLKAFPSIQELIVSYNN 244

Query: 360 ITTLDSVPGMFS--SLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKL 413
           I T+  V    +   L EL L+ N I +W EV  LG LP LK LNL S  + +I+ 
Sbjct: 245 IETISGVEESLNIMKLTELSLEHNLISNWNEVLKLGILPCLKGLNLNSNKIEDIRF 300




Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91079236|ref|XP_970901.1| PREDICTED: similar to beta-tubulin cofactor E [Tribolium castaneum] Back     alignment and taxonomy information
>gi|119590429|gb|EAW70023.1| tubulin-specific chaperone e, isoform CRA_c [Homo sapiens] Back     alignment and taxonomy information
>gi|326429505|gb|EGD75075.1| hypothetical protein PTSG_06731 [Salpingoeca sp. ATCC 50818] Back     alignment and taxonomy information
>gi|383850534|ref|XP_003700850.1| PREDICTED: tubulin-specific chaperone E-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|77748012|gb|AAI07630.1| Zgc:123075 [Danio rerio] Back     alignment and taxonomy information
>gi|307182233|gb|EFN69564.1| Tubulin-specific chaperone E [Camponotus floridanus] Back     alignment and taxonomy information
>gi|307210248|gb|EFN86898.1| Tubulin-specific chaperone E [Harpegnathos saltator] Back     alignment and taxonomy information
>gi|332026204|gb|EGI66346.1| Tubulin-specific chaperone E [Acromyrmex echinatior] Back     alignment and taxonomy information
>gi|350400723|ref|XP_003485937.1| PREDICTED: tubulin-specific chaperone E-like [Bombus impatiens] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query421
ZFIN|ZDB-GENE-051030-120 521 tbce "tubulin folding cofactor 0.287 0.232 0.429 7e-28
UNIPROTKB|Q32KS0 528 TBCE "Tubulin-specific chapero 0.524 0.418 0.333 1.6e-22
UNIPROTKB|Q5U508 522 tbce "Tubulin-specific chapero 0.496 0.400 0.337 8.5e-22
UNIPROTKB|Q15813 527 TBCE "Tubulin-specific chapero 0.505 0.404 0.327 1.1e-20
UNIPROTKB|Q5RBD9 527 TBCE "Tubulin-specific chapero 0.503 0.402 0.334 1.1e-20
ASPGD|ASPL0000026995 606 AN5531 [Emericella nidulans (t 0.258 0.179 0.422 1.4e-20
FB|FBgn0033055 542 tbce "tubulin-specific chapero 0.522 0.405 0.288 1.6e-20
MGI|MGI:1917680 524 Tbce "tubulin-specific chapero 0.520 0.417 0.314 1.3e-19
DICTYBASE|DDB_G0269990 525 tbcE "tubulin binding cofactor 0.491 0.394 0.336 4.9e-19
UNIPROTKB|B7Z3P1 578 TBCE "cDNA FLJ59210, highly si 0.465 0.339 0.327 1.4e-18
ZFIN|ZDB-GENE-051030-120 tbce "tubulin folding cofactor E" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
 Score = 277 (102.6 bits), Expect = 7.0e-28, Sum P(2) = 7.0e-28
 Identities = 55/128 (42%), Positives = 82/128 (64%)

Query:   180 VMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHS 239
             ++++ +G RVC  +G RGT+RYVG V  T GVW G++WD   RGKHDGSH+GV+YF    
Sbjct:     2 MLDEAVGRRVC-CDGERGTVRYVGPVPPTAGVWLGVEWDHPERGKHDGSHDGVRYFTCRH 60

Query:   240 TTSGSFMRRDKLNFGSSFMEALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVH 299
              T GSF+R  K +FG  ++ AL ++Y     E+T     EE+K  I++  + +VGF+ V 
Sbjct:    61 PTGGSFVRPQKASFGVDYVTALKQRYEVEIEEVTA----EEMK--ISSKTVVMVGFENVK 114

Query:   300 EEQNTNKL 307
             ++Q+   L
Sbjct:   115 KKQSVKNL 122


GO:0007023 "post-chaperonin tubulin folding pathway" evidence=ISS
GO:0005737 "cytoplasm" evidence=IEA
GO:0005856 "cytoskeleton" evidence=IEA
UNIPROTKB|Q32KS0 TBCE "Tubulin-specific chaperone E" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|Q5U508 tbce "Tubulin-specific chaperone E" [Xenopus laevis (taxid:8355)] Back     alignment and assigned GO terms
UNIPROTKB|Q15813 TBCE "Tubulin-specific chaperone E" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q5RBD9 TBCE "Tubulin-specific chaperone E" [Pongo abelii (taxid:9601)] Back     alignment and assigned GO terms
ASPGD|ASPL0000026995 AN5531 [Emericella nidulans (taxid:162425)] Back     alignment and assigned GO terms
FB|FBgn0033055 tbce "tubulin-specific chaperone E" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
MGI|MGI:1917680 Tbce "tubulin-specific chaperone E" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
DICTYBASE|DDB_G0269990 tbcE "tubulin binding cofactor E" [Dictyostelium discoideum (taxid:44689)] Back     alignment and assigned GO terms
UNIPROTKB|B7Z3P1 TBCE "cDNA FLJ59210, highly similar to Tubulin-specific chaperone E" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query421
smart0105268 smart01052, CAP_GLY, Cytoskeleton-associated prote 4e-21
pfam0130267 pfam01302, CAP_GLY, CAP-Gly domain 8e-21
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 4e-06
COG5244 669 COG5244, NIP100, Dynactin complex subunit involved 7e-06
pfam1279943 pfam12799, LRR_4, Leucine Rich repeats (2 copies) 8e-06
>gnl|CDD|214997 smart01052, CAP_GLY, Cytoskeleton-associated proteins (CAPs) are involved in the organisation of microtubules and transportation of vesicles and organelles along the cytoskeletal network Back     alignment and domain information
 Score = 86.1 bits (214), Expect = 4e-21
 Identities = 30/68 (44%), Positives = 38/68 (55%), Gaps = 2/68 (2%)

Query: 185 IGLRV-CDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSG 243
           +G RV     G RGT+RYVG      GVW G++ D   RGK+DGS  GV+YF       G
Sbjct: 1   VGDRVEVGGGGRRGTVRYVGPTPFAPGVWVGVELDEPLRGKNDGSVKGVRYF-ECPPKHG 59

Query: 244 SFMRRDKL 251
            F+R  K+
Sbjct: 60  IFVRPSKV 67


A conserved motif, CAP-Gly, has been identified in a number of CAPs, including CLIP-170 and dynactins. The crystal structure of Caenorhabditis elegans F53F4.3 protein CAP-Gly domain was recently solved. The domain contains three beta-strands. The most conserved sequence, GKNDG, is located in two consecutive sharp turns on the surface, forming the entrance to a groove. Length = 68

>gnl|CDD|216424 pfam01302, CAP_GLY, CAP-Gly domain Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|227569 COG5244, NIP100, Dynactin complex subunit involved in mitotic spindle partitioning in anaphase B [Cell division and chromosome partitioning] Back     alignment and domain information
>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 421
KOG3207|consensus 505 99.97
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.86
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.85
KOG2982|consensus418 99.78
KOG4194|consensus 873 99.77
KOG0444|consensus 1255 99.7
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.67
KOG0472|consensus565 99.66
KOG3207|consensus505 99.66
KOG4194|consensus 873 99.65
KOG0444|consensus 1255 99.62
KOG0618|consensus 1081 99.59
KOG0472|consensus565 99.49
KOG1644|consensus233 99.37
KOG4237|consensus 498 99.31
PF0130269 CAP_GLY: CAP-Gly domain; InterPro: IPR000938 Cytos 99.28
KOG0618|consensus 1081 99.26
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.21
KOG3206|consensus234 99.1
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.0
PLN03210 1153 Resistant to P. syringae 6; Provisional 98.99
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.97
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 98.94
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 98.92
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 98.87
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 98.82
KOG4237|consensus498 98.81
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.71
PLN03210 1153 Resistant to P. syringae 6; Provisional 98.68
KOG0617|consensus 264 98.65
KOG2123|consensus388 98.63
KOG0617|consensus 264 98.63
COG5244 669 NIP100 Dynactin complex subunit involved in mitoti 98.62
KOG2739|consensus260 98.49
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.4
PLN03150623 hypothetical protein; Provisional 98.39
KOG2982|consensus 418 98.35
PLN03150623 hypothetical protein; Provisional 98.31
KOG1259|consensus490 98.31
KOG0971|consensus 1243 98.22
KOG1259|consensus490 98.2
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.14
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.98
KOG1644|consensus233 97.95
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.94
KOG4579|consensus177 97.76
KOG4579|consensus177 97.72
KOG1909|consensus382 97.68
KOG0531|consensus 414 97.59
KOG1859|consensus 1096 97.55
KOG1859|consensus 1096 97.53
KOG1909|consensus382 97.52
KOG4568|consensus 664 97.51
KOG3665|consensus 699 97.42
KOG2123|consensus 388 97.41
COG4886 394 Leucine-rich repeat (LRR) protein [Function unknow 97.3
KOG0531|consensus 414 97.01
KOG2120|consensus419 96.99
KOG2739|consensus260 96.97
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 96.96
KOG0532|consensus 722 96.95
KOG3763|consensus585 96.93
KOG0532|consensus 722 96.63
KOG4658|consensus889 96.59
KOG3556|consensus 724 96.51
KOG3665|consensus 699 96.39
KOG2120|consensus419 96.36
KOG4658|consensus889 95.76
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 95.67
KOG3763|consensus 585 93.89
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 93.73
KOG0241|consensus1714 93.09
KOG4568|consensus 664 92.89
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 92.82
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 91.56
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 91.12
smart0036526 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily 90.79
PRK15386 426 type III secretion protein GogB; Provisional 90.49
smart0037026 LRR Leucine-rich repeats, outliers. 89.29
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 89.29
PRK15386 426 type III secretion protein GogB; Provisional 89.1
KOG1947|consensus482 88.36
KOG4308|consensus478 87.94
smart0044626 LRRcap occurring C-terminal to leucine-rich repeat 87.68
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 87.53
smart0037026 LRR Leucine-rich repeats, outliers. 87.53
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 85.99
smart0036526 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily 83.83
KOG0473|consensus326 83.79
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 83.2
KOG1947|consensus482 82.83
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 81.34
smart0036426 LRR_BAC Leucine-rich repeats, bacterial type. 80.11
>KOG3207|consensus Back     alignment and domain information
Probab=99.97  E-value=7e-31  Score=248.76  Aligned_cols=228  Identities=32%  Similarity=0.627  Sum_probs=189.9

Q ss_pred             cCCCCceEEeecCceeEEEEecccCCCCCcEEEEEecCCCCCCCCCeeCCEEeEecCCCCceeEEecCccccCchhHHHh
Q psy9363         182 EDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFMEAL  261 (421)
Q Consensus       182 ~~~i~~rv~~l~~~~~~~r~~G~ip~~~g~~~gle~d~~~~g~~~G~~~g~~~f~~~~~~~gsf~~~~~l~~g~~~~~al  261 (421)
                      .+.+|.|+. +++.++|+||+|.|+++.|.|+||||||..||||+|.++|.+||+|..|+.|||+++.++..+.++..++
T Consensus         2 ~~~IG~Rvk-I~~~~~Tvr~iG~V~g~~~~w~GvEWDd~~RGKH~G~vdgk~YF~~q~P~GGSFik~~kV~~p~d~~~t~   80 (505)
T KOG3207|consen    2 TMEIGTRVK-IGGEIATVRYIGEVEGNNSKWYGVEWDDPVRGKHDGIVDGKRYFQTQHPNGGSFIKPGKVKFPTDLLRTF   80 (505)
T ss_pred             ceeccceEE-EcCEEEEEEEEEEEcCCCCcceeeEecCCCccccCceecceeeeeeecCCCccccCCccCCCCccHHHHH
Confidence            356899998 9999999999999999999999999999999999999999999999999999999999999888999999


Q ss_pred             hhhhccccchhhhccccceeeeeecCceeEeecccchhhhh----CCCccCCCC---CCCc--hhhhcCCCCCccEEEee
Q psy9363         262 HRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQ----NTNKLPIPN---DTSG--VMEQIFPQGHIHTLTLG  332 (421)
Q Consensus       262 ~~~y~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~l~~~~----~L~~l~l~~---~~~~--~~~~~l~~~~L~~L~Ls  332 (421)
                      .++|......    +.+....+.++++.+|.+||+++..++    +|+.+.|.+   +..+  .....|  ++++.||||
T Consensus        81 ~ery~e~~s~----~sd~~~~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~--~~v~~LdLS  154 (505)
T KOG3207|consen   81 KERYYEKYSY----SSDLESVLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKIL--PNVRDLDLS  154 (505)
T ss_pred             HHHHHHhhcC----CcchhhHhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhC--Ccceeecch
Confidence            9999877542    222233456889999999999999888    566667776   3333  467889  999999999


Q ss_pred             Ccccc-hhhHHHHhccCCC-cEEEccCCcCcc-cCCC-------------------------------------------
Q psy9363         333 NMGYI-WADILKLLANFPV-TCLKLPSNRITT-LDSV-------------------------------------------  366 (421)
Q Consensus       333 ~N~l~-~~~i~~~~~~l~~-~~L~L~~N~l~~-l~~~-------------------------------------------  366 (421)
                      .|.|+ |..+.+++..+|+ +.|+|+.|++.- ....                                           
T Consensus       155 ~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~  234 (505)
T KOG3207|consen  155 RNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEI  234 (505)
T ss_pred             hhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccc
Confidence            99999 9999999999999 999999999962 1000                                           


Q ss_pred             -------CCCCCCCcEEECcCCCCCCCCcccccCccccccccccccccCcccCCCCC
Q psy9363         367 -------PGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTNLRNIKLNKE  416 (421)
Q Consensus       367 -------~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~i~~p~~  416 (421)
                             ...+..|++|||++|++-+.+....++.+|.|..|+++.+.+++|..|+.
T Consensus       235 ~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~  291 (505)
T KOG3207|consen  235 ILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDV  291 (505)
T ss_pred             cceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCc
Confidence                   02244567777777777776666677788888888888888888888876



>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG2982|consensus Back     alignment and domain information
>KOG4194|consensus Back     alignment and domain information
>KOG0444|consensus Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG0472|consensus Back     alignment and domain information
>KOG3207|consensus Back     alignment and domain information
>KOG4194|consensus Back     alignment and domain information
>KOG0444|consensus Back     alignment and domain information
>KOG0618|consensus Back     alignment and domain information
>KOG0472|consensus Back     alignment and domain information
>KOG1644|consensus Back     alignment and domain information
>KOG4237|consensus Back     alignment and domain information
>PF01302 CAP_GLY: CAP-Gly domain; InterPro: IPR000938 Cytoskeleton-associated proteins (CAP) are made of three distinct parts, an N-terminal section that is most probably globular and contains the CAP-Gly domain, a large central region predicted to be in an alpha-helical coiled-coil conformation and, finally, a short C-terminal globular domain Back     alignment and domain information
>KOG0618|consensus Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG3206|consensus Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG4237|consensus Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG0617|consensus Back     alignment and domain information
>KOG2123|consensus Back     alignment and domain information
>KOG0617|consensus Back     alignment and domain information
>COG5244 NIP100 Dynactin complex subunit involved in mitotic spindle partitioning in anaphase B [Cell division and chromosome partitioning] Back     alignment and domain information
>KOG2739|consensus Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG2982|consensus Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1259|consensus Back     alignment and domain information
>KOG0971|consensus Back     alignment and domain information
>KOG1259|consensus Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG1644|consensus Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG4579|consensus Back     alignment and domain information
>KOG4579|consensus Back     alignment and domain information
>KOG1909|consensus Back     alignment and domain information
>KOG0531|consensus Back     alignment and domain information
>KOG1859|consensus Back     alignment and domain information
>KOG1859|consensus Back     alignment and domain information
>KOG1909|consensus Back     alignment and domain information
>KOG4568|consensus Back     alignment and domain information
>KOG3665|consensus Back     alignment and domain information
>KOG2123|consensus Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0531|consensus Back     alignment and domain information
>KOG2120|consensus Back     alignment and domain information
>KOG2739|consensus Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG0532|consensus Back     alignment and domain information
>KOG3763|consensus Back     alignment and domain information
>KOG0532|consensus Back     alignment and domain information
>KOG4658|consensus Back     alignment and domain information
>KOG3556|consensus Back     alignment and domain information
>KOG3665|consensus Back     alignment and domain information
>KOG2120|consensus Back     alignment and domain information
>KOG4658|consensus Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG3763|consensus Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG0241|consensus Back     alignment and domain information
>KOG4568|consensus Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG1947|consensus Back     alignment and domain information
>KOG4308|consensus Back     alignment and domain information
>smart00446 LRRcap occurring C-terminal to leucine-rich repeats Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily Back     alignment and domain information
>KOG0473|consensus Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG1947|consensus Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query421
1whg_A113 Solution Structure Of The Cap-Gly Domain In Mouse T 3e-06
1txq_A93 Crystal Structure Of The Eb1 C-Terminal Domain Comp 8e-06
2hkn_A97 Crystal Structure Of The Cap-Gly Domain Of Human Dy 9e-06
2coy_A112 Solution Structure Of The Cap-Gly Domain In Human D 9e-06
3tq7_P71 Eb1cEB3C HETERODIMER IN COMPLEX WITH THE CAP-Gly Do 1e-05
2hl3_A97 Crystal Structure Of The A49m Mutant Cap-Gly Domain 2e-05
1whh_A102 Solution Structure Of The 2nd Cap-Gly Domain In Mou 2e-05
2cp0_A95 Solution Structure Of The 1st Cap-Gly Domain In Hum 2e-05
1lpl_A95 Structural Genomics Of Caenorhabditis Elegans: Cap- 7e-05
1tov_A98 Structural Genomics Of Caenorhabditis Elegans: Cap- 8e-05
2z0w_A96 Crystal Structure Of The 2nd Cap-Gly Domain In Huma 4e-04
>pdb|1WHG|A Chain A, Solution Structure Of The Cap-Gly Domain In Mouse Tubulin Specific Chaperone B Length = 113 Back     alignment and structure

Iteration: 1

Score = 49.7 bits (117), Expect = 3e-06, Method: Composition-based stats. Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 6/102 (5%) Query: 159 DEKRRAEFLEANPRVGDNYFQVMEDDIG----LRVCDSEGHRGTIRYVGSVEGTQGVWYG 214 +E R + EA R+ + Q +G +R D RGT+ YVG + G W G Sbjct: 9 EELRAQQEAEAAQRLSEEKAQASAISVGSRCEVRAPDHSLRRGTVMYVGLTDFKPGYWVG 68 Query: 215 IDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSS 256 + +D E GK+DGS NG +YF + G+F++ + G S Sbjct: 69 VRYD-EPLGKNDGSVNGKRYFECQAKY-GAFVKPSAVTVGDS 108
>pdb|1TXQ|A Chain A, Crystal Structure Of The Eb1 C-Terminal Domain Complexed With The Cap-Gly Domain Of P150glued Length = 93 Back     alignment and structure
>pdb|2HKN|A Chain A, Crystal Structure Of The Cap-Gly Domain Of Human Dynactin-1 (P150- Glued) Length = 97 Back     alignment and structure
>pdb|2COY|A Chain A, Solution Structure Of The Cap-Gly Domain In Human Dynactin 1 Length = 112 Back     alignment and structure
>pdb|3TQ7|P Chain P, Eb1cEB3C HETERODIMER IN COMPLEX WITH THE CAP-Gly Domain Of P150glued Length = 71 Back     alignment and structure
>pdb|2HL3|A Chain A, Crystal Structure Of The A49m Mutant Cap-Gly Domain Of Human Dynactin-1 (P150-Glued) In Complex With Human Eb1 C- Terminal Hexapeptide Length = 97 Back     alignment and structure
>pdb|1WHH|A Chain A, Solution Structure Of The 2nd Cap-Gly Domain In Mouse Clip170-Related 59kda Protein Clipr-59 Length = 102 Back     alignment and structure
>pdb|2CP0|A Chain A, Solution Structure Of The 1st Cap-Gly Domain In Human Clip- 170-Related Protein Clipr59 Length = 95 Back     alignment and structure
>pdb|1LPL|A Chain A, Structural Genomics Of Caenorhabditis Elegans: Cap-Gly Domain Of F53f4.3 Length = 95 Back     alignment and structure
>pdb|1TOV|A Chain A, Structural Genomics Of Caenorhabditis Elegans: Cap-Gly Domain Of F53f4.3 Length = 98 Back     alignment and structure
>pdb|2Z0W|A Chain A, Crystal Structure Of The 2nd Cap-Gly Domain In Human Restin- Like Protein 2 Reveals A Swapped-Dimer Length = 96 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query421
2z0w_A96 CAP-Gly domain-containing linker protein 4; altern 7e-25
2cp5_A141 Restin; microtubule binding, cytoskeleton associat 1e-23
1ixd_A104 Cylindromatosis tumour-suppressor CYLD; structural 2e-23
2cp0_A95 Clipr-59 protein, clipr59; microtubule binding, cy 3e-23
2cow_A100 Kinesin-like protein KIF13B; microtubule binding, 5e-23
2e3h_A90 Restin; CAP-Gly, cytoplasmic linker, tubulin bindi 7e-23
1whh_A102 Clipr-59; microtubule binding, trans-golgi network 7e-23
2cp3_A84 CLIP-115, KIAA0291; microtubule binding, cytoskele 8e-23
2e3i_A86 Restin; CAP-Gly, cytoplasmic linker, tubulin bindi 9e-23
3rdv_A72 CAP-Gly domain-containing linker protein 1; cytosk 1e-22
2coy_A112 Dynactin-1; microtubule binding, cytoskeleton asso 2e-22
1whk_A91 1700024K14RIK, riken cDNA 1700024K14; structural g 2e-22
1whj_A102 1700024K14RIK, riken cDNA 1700024K14; structural g 3e-22
2cp2_A95 CLIP-115, KIAA0291; microtubule binding, cytoskele 3e-22
1txq_A93 Dynactin 1; protein complex, structural protein/pr 4e-22
2coz_A122 CAP350, centrosome-associated protein 350; microtu 6e-22
2cp6_A172 Restin; microtubule binding, cytoskeleton associat 1e-21
1lpl_A95 Hypothetical 25.4 kDa protein F53F4.3 in chromosom 4e-21
1whg_A113 Tubulin specific chaperone B; microtubule binding, 3e-20
1whl_A95 Cylindromatosis tumor suppressor CYLD; deubiquitin 1e-18
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-08
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 3e-06
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 9e-05
2z66_A 306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-08
2z66_A 306 Variable lymphocyte receptor B, TOLL-like recepto; 4e-07
2z66_A 306 Variable lymphocyte receptor B, TOLL-like recepto; 7e-07
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-05
2z66_A 306 Variable lymphocyte receptor B, TOLL-like recepto; 5e-04
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 3e-08
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 2e-05
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-08
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 3e-04
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 5e-08
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 6e-07
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 1e-06
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 2e-06
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 5e-06
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 5e-08
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-06
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 6e-04
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 6e-08
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-06
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 4e-06
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-05
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 8e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-04
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-04
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 7e-04
4fmz_A347 Internalin; leucine rich repeat, structural genomi 7e-08
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 4e-07
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-06
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 2e-06
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 4e-06
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 5e-06
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 8e-06
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 1e-05
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 2e-05
4fmz_A 347 Internalin; leucine rich repeat, structural genomi 2e-05
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-05
4fmz_A347 Internalin; leucine rich repeat, structural genomi 6e-05
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 9e-08
1xku_A 330 Decorin; proteoglycan, leucine-rich repeat, struct 9e-08
1xku_A 330 Decorin; proteoglycan, leucine-rich repeat, struct 2e-07
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 3e-06
1xku_A 330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-05
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 2e-04
1xku_A 330 Decorin; proteoglycan, leucine-rich repeat, struct 5e-04
1whm_A92 Cylindromatosis tumor suppressor CYLD; deubiquitin 1e-07
4ezg_A197 Putative uncharacterized protein; internalin-A, le 1e-07
4ezg_A197 Putative uncharacterized protein; internalin-A, le 7e-06
4ezg_A197 Putative uncharacterized protein; internalin-A, le 1e-05
1h6u_A 308 Internalin H; cell adhesion, leucine rich repeat, 1e-07
1h6u_A 308 Internalin H; cell adhesion, leucine rich repeat, 2e-07
1h6u_A 308 Internalin H; cell adhesion, leucine rich repeat, 6e-07
1h6u_A 308 Internalin H; cell adhesion, leucine rich repeat, 7e-07
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 2e-06
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 2e-07
1ds9_A 198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 9e-07
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 7e-06
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 7e-05
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 8e-04
1h6t_A 291 Internalin B; cell adhesion, leucine rich repeat, 2e-07
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 7e-07
1h6t_A 291 Internalin B; cell adhesion, leucine rich repeat, 1e-06
1h6t_A 291 Internalin B; cell adhesion, leucine rich repeat, 3e-06
1h6t_A 291 Internalin B; cell adhesion, leucine rich repeat, 7e-06
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-07
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-05
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-05
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-05
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 5e-05
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-04
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 6e-04
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 8e-04
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 2e-07
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 2e-06
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 4e-06
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 6e-06
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 1e-05
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 2e-04
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 2e-07
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 7e-07
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 5e-06
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 6e-06
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 1e-05
2ft3_A 332 Biglycan; proteoglycan, dimer interface, structura 3e-07
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 3e-07
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 1e-05
2ft3_A 332 Biglycan; proteoglycan, dimer interface, structura 1e-05
2ft3_A 332 Biglycan; proteoglycan, dimer interface, structura 4e-05
2ft3_A 332 Biglycan; proteoglycan, dimer interface, structura 6e-04
1o6v_A 466 Internalin A; bacterial infection, extracellular r 3e-07
1o6v_A 466 Internalin A; bacterial infection, extracellular r 6e-07
1o6v_A 466 Internalin A; bacterial infection, extracellular r 7e-07
1o6v_A 466 Internalin A; bacterial infection, extracellular r 2e-06
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-06
1o6v_A 466 Internalin A; bacterial infection, extracellular r 3e-06
1o6v_A 466 Internalin A; bacterial infection, extracellular r 4e-06
1o6v_A 466 Internalin A; bacterial infection, extracellular r 4e-06
1o6v_A 466 Internalin A; bacterial infection, extracellular r 5e-06
1o6v_A 466 Internalin A; bacterial infection, extracellular r 2e-05
1o6v_A 466 Internalin A; bacterial infection, extracellular r 2e-05
1o6v_A 466 Internalin A; bacterial infection, extracellular r 2e-05
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-05
1o6v_A 466 Internalin A; bacterial infection, extracellular r 4e-05
1o6v_A 466 Internalin A; bacterial infection, extracellular r 5e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-07
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-06
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 8e-06
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 2e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 3e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 5e-05
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 9e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 9e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 2e-04
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-04
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 6e-04
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 7e-04
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 5e-07
1xeu_A 263 Internalin C; cellular invasion, leucine-rich repe 5e-07
1xeu_A 263 Internalin C; cellular invasion, leucine-rich repe 1e-06
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 5e-06
1xeu_A 263 Internalin C; cellular invasion, leucine-rich repe 3e-04
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 7e-07
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 2e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-05
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 4e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 4e-05
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 5e-05
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 7e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-04
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 7e-07
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 1e-05
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-05
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-05
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-05
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 1e-04
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 7e-04
2z80_A 353 TOLL-like receptor 2, variable lymphocyte recepto; 9e-07
2z80_A 353 TOLL-like receptor 2, variable lymphocyte recepto; 1e-04
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 2e-06
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 4e-06
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 6e-06
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 1e-05
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 2e-05
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 3e-05
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 3e-05
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-05
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 6e-04
4ay9_X 350 Follicle-stimulating hormone receptor; hormone-rec 2e-06
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-06
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 9e-06
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-05
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 3e-05
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 6e-05
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 7e-05
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-04
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 2e-06
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 4e-05
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 6e-05
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 6e-05
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 8e-05
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 1e-04
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 1e-04
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 4e-04
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-06
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 6e-06
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-05
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-05
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-05
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-04
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 5e-04
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 6e-04
2z62_A 276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-06
2z62_A 276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-05
2z62_A 276 TOLL-like receptor 4, variable lymphocyte recepto; 3e-05
2z62_A 276 TOLL-like receptor 4, variable lymphocyte recepto; 3e-04
1ozn_A 285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 2e-06
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-05
1ozn_A 285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 2e-05
1ozn_A 285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 2e-05
1ozn_A 285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-04
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 4e-04
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-06
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-05
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-05
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 4e-05
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-04
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 4e-04
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 4e-04
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-04
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 7e-04
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 3e-06
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 4e-06
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 7e-06
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-05
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-05
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-05
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-04
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 5e-04
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 6e-04
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 5e-06
2z7x_B 520 TOLL-like receptor 1, variable lymphocyte recepto; 2e-05
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 7e-06
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 3e-04
3o53_A 317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 7e-06
3o53_A 317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-05
3o53_A 317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-05
3o53_A 317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-05
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 5e-05
3o53_A 317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 6e-05
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 8e-06
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 8e-05
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 8e-05
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-04
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 2e-04
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-04
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 7e-04
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 9e-06
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 2e-05
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 4e-05
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 6e-05
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 5e-04
1jl5_A 454 Outer protein YOPM; leucine-rich repeat, molecular 1e-05
1jl5_A 454 Outer protein YOPM; leucine-rich repeat, molecular 4e-04
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-05
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 1e-04
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 3e-04
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 3e-04
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 5e-04
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 7e-04
2xwt_C 239 Thyrotropin receptor; signaling protein-immune sys 2e-05
2xwt_C 239 Thyrotropin receptor; signaling protein-immune sys 3e-05
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-04
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 3e-05
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 3e-05
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 9e-04
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 7e-05
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 2e-04
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 6e-04
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 9e-05
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 3e-04
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 9e-05
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 5e-04
1p9a_G 290 Platelet glycoprotein IB alpha chain precursor; pl 1e-04
1p9a_G 290 Platelet glycoprotein IB alpha chain precursor; pl 3e-04
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 5e-04
4fcg_A 328 Uncharacterized protein; structural genomics, PSI- 2e-04
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-04
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-04
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 3e-04
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 3e-04
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 3e-04
3a79_B 562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 3e-04
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 3e-04
2v9t_B 220 SLIT homolog 2 protein N-product; structural prote 9e-04
2ifg_A 347 High affinity nerve growth factor receptor; TRK, T 4e-04
>2z0w_A CAP-Gly domain-containing linker protein 4; alternative splicing, ANK repeat, protein binding, structural genomics, NPPSFA; 2.50A {Homo sapiens} Length = 96 Back     alignment and structure
 Score = 96.7 bits (241), Expect = 7e-25
 Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 2/81 (2%)

Query: 185 IGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGS 244
           +G RV       GTIR+ G+     G WYGI+ + +  GK+DGS  GV+YF   S   G 
Sbjct: 13  LGERVLVVGQRLGTIRFFGTTNFAPGYWYGIELE-KPHGKNDGSVGGVQYFSC-SPRYGI 70

Query: 245 FMRRDKLNFGSSFMEALHRKY 265
           F    ++   +  ++ L    
Sbjct: 71  FAPPSRVQRVTDSLDTLSEIS 91


>2cp5_A Restin; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 141 Back     alignment and structure
>1ixd_A Cylindromatosis tumour-suppressor CYLD; structural genomics, riken structural genomics/proteomics initiative, RSGI, antitumor protein; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 104 Back     alignment and structure
>2cp0_A Clipr-59 protein, clipr59; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 95 Back     alignment and structure
>2cow_A Kinesin-like protein KIF13B; microtubule binding, cytoskeleton associated protein, KIAA0639, kinesin-like protein gakin, structural genomics; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 100 Back     alignment and structure
>2e3h_A Restin; CAP-Gly, cytoplasmic linker, tubulin binding, structural protein; 1.45A {Homo sapiens} SCOP: b.34.10.1 PDB: 2e4h_A Length = 90 Back     alignment and structure
>1whh_A Clipr-59; microtubule binding, trans-golgi network, structural genomics, riken structural genomics/proteomics initiative, RSGI, structural protein; NMR {Mus musculus} SCOP: b.34.10.1 Length = 102 Back     alignment and structure
>2cp3_A CLIP-115, KIAA0291; microtubule binding, cytoskeleton associated protein, CYLN2, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 84 Back     alignment and structure
>2e3i_A Restin; CAP-Gly, cytoplasmic linker, tubulin binding, structural protein; 2.00A {Homo sapiens} SCOP: b.34.10.1 Length = 86 Back     alignment and structure
>3rdv_A CAP-Gly domain-containing linker protein 1; cytoskeletal protein, CAP Gly protein complex, structural PR; HET: BME; 1.75A {Homo sapiens} PDB: 2qk0_A Length = 72 Back     alignment and structure
>2coy_A Dynactin-1; microtubule binding, cytoskeleton associated protein, P150- glued, DAP-150, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 112 Back     alignment and structure
>1whk_A 1700024K14RIK, riken cDNA 1700024K14; structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.34.10.1 Length = 91 Back     alignment and structure
>1whj_A 1700024K14RIK, riken cDNA 1700024K14; structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.34.10.1 Length = 102 Back     alignment and structure
>2cp2_A CLIP-115, KIAA0291; microtubule binding, cytoskeleton associated protein, CYLN2, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 PDB: 2cp7_A Length = 95 Back     alignment and structure
>1txq_A Dynactin 1; protein complex, structural protein/protein binding complex; 1.80A {Homo sapiens} SCOP: b.34.10.1 PDB: 2hqh_A 2hkq_B 2hkn_A 2pzo_A 3e2u_A 2hl5_C 2hl3_A 3tq7_P Length = 93 Back     alignment and structure
>2coz_A CAP350, centrosome-associated protein 350; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 122 Back     alignment and structure
>2cp6_A Restin; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 172 Back     alignment and structure
>1lpl_A Hypothetical 25.4 kDa protein F53F4.3 in chromosome V; structural genomics, CAP-Gly domain, cytoskeleton, tubulin, PSI; 1.77A {Caenorhabditis elegans} SCOP: b.34.10.1 PDB: 1tov_A Length = 95 Back     alignment and structure
>1whg_A Tubulin specific chaperone B; microtubule binding, cytoskeleton associated protein, ckapi, structural genomics; NMR {Mus musculus} SCOP: b.34.10.1 Length = 113 Back     alignment and structure
>1whl_A Cylindromatosis tumor suppressor CYLD; deubiquitinating enzyme, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 95 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1whm_A Cylindromatosis tumor suppressor CYLD; deubiquitinating enzyme, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.10.1 Length = 92 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query421
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.89
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.87
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.87
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.85
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.84
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.83
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.82
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.82
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 99.81
2z7x_B 520 TOLL-like receptor 1, variable lymphocyte recepto; 99.81
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.8
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 99.8
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.8
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.8
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.8
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.79
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 99.78
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.78
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.78
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.78
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.77
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.77
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.77
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.76
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.76
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.75
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.74
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.74
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.73
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.73
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.73
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.72
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.72
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.72
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.72
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.71
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 99.71
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.71
3a79_B 562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.7
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 99.7
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.69
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.69
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.69
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.68
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.67
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.67
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.67
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.67
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.66
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.65
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.64
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.63
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.63
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.62
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.61
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.61
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.61
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.59
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.59
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.58
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.58
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.57
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 99.57
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.57
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.57
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.56
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 99.55
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.55
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.54
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.54
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.53
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.52
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.51
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.5
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.5
2z0w_A96 CAP-Gly domain-containing linker protein 4; altern 99.49
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.47
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.45
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.45
4b6m_A84 Tubulin-specific chaperone, putative; structural p 99.44
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.44
1lpl_A95 Hypothetical 25.4 kDa protein F53F4.3 in chromosom 99.44
2e3i_A86 Restin; CAP-Gly, cytoplasmic linker, tubulin bindi 99.44
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.44
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.43
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.43
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.43
3rdv_A72 CAP-Gly domain-containing linker protein 1; cytosk 99.43
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.43
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.42
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.41
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.41
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.4
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.39
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.39
1ixd_A104 Cylindromatosis tumour-suppressor CYLD; structural 99.38
2e3h_A90 Restin; CAP-Gly, cytoplasmic linker, tubulin bindi 99.37
2cp2_A95 CLIP-115, KIAA0291; microtubule binding, cytoskele 99.36
1whg_A113 Tubulin specific chaperone B; microtubule binding, 99.36
2cp0_A95 Clipr-59 protein, clipr59; microtubule binding, cy 99.35
2cp3_A84 CLIP-115, KIAA0291; microtubule binding, cytoskele 99.34
1whh_A102 Clipr-59; microtubule binding, trans-golgi network 99.34
1whl_A95 Cylindromatosis tumor suppressor CYLD; deubiquitin 99.34
1txq_A93 Dynactin 1; protein complex, structural protein/pr 99.34
1whk_A91 1700024K14RIK, riken cDNA 1700024K14; structural g 99.33
1whj_A102 1700024K14RIK, riken cDNA 1700024K14; structural g 99.32
2cp6_A172 Restin; microtubule binding, cytoskeleton associat 99.32
2coz_A122 CAP350, centrosome-associated protein 350; microtu 99.31
2coy_A112 Dynactin-1; microtubule binding, cytoskeleton asso 99.3
2cp5_A141 Restin; microtubule binding, cytoskeleton associat 99.29
2cow_A100 Kinesin-like protein KIF13B; microtubule binding, 99.28
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.26
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.24
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.24
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.24
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.23
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.2
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.19
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.18
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.17
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.17
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.16
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.15
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.15
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.13
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.11
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.1
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.1
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.1
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.1
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.1
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.08
2z62_A 276 TOLL-like receptor 4, variable lymphocyte recepto; 99.08
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.08
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.08
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.07
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 99.05
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.04
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.04
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.04
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.01
4ay9_X 350 Follicle-stimulating hormone receptor; hormone-rec 99.0
1whm_A92 Cylindromatosis tumor suppressor CYLD; deubiquitin 98.98
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.98
4ezg_A197 Putative uncharacterized protein; internalin-A, le 98.96
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 98.96
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.95
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.94
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.93
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 98.93
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.91
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 98.91
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.88
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 98.88
1xeu_A 263 Internalin C; cellular invasion, leucine-rich repe 98.88
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 98.85
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.83
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 98.82
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.8
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.79
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 98.76
2ifg_A 347 High affinity nerve growth factor receptor; TRK, T 98.7
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.65
2ifg_A 347 High affinity nerve growth factor receptor; TRK, T 98.46
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.41
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 98.38
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 98.38
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.22
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 97.92
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 97.5
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 97.32
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 97.16
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 97.13
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 97.0
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 96.87
4fdw_A401 Leucine rich hypothetical protein; putative cell s 96.79
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 96.61
4fdw_A401 Leucine rich hypothetical protein; putative cell s 96.24
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 95.67
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 95.34
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 93.27
4gt6_A394 Cell surface protein; leucine rich repeats, putati 92.58
4gt6_A394 Cell surface protein; leucine rich repeats, putati 88.55
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 87.9
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 86.82
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 82.23
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
Probab=99.89  E-value=1.2e-24  Score=233.42  Aligned_cols=103  Identities=21%  Similarity=0.258  Sum_probs=85.7

Q ss_pred             CCCchhhhcCCCCCccEEEeeCcccchhhHHHHhccCCC-cEEEccCCcCc-ccCCCCCCCCCCcEEECcCCCCCCCCcc
Q psy9363         312 DTSGVMEQIFPQGHIHTLTLGNMGYIWADILKLLANFPV-TCLKLPSNRIT-TLDSVPGMFSSLEELYLQENNIVDWGEV  389 (421)
Q Consensus       312 ~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~i~~~~~~l~~-~~L~L~~N~l~-~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  389 (421)
                      +.+|..+..+  ++|+.|+|++|.++ +.+|..+..++. +.|+|++|+++ .+|..++.+++|+.|||++|++ .+.++
T Consensus       622 g~~~~~~~~l--~~L~~LdLs~N~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l-~g~ip  697 (768)
T 3rgz_A          622 GHTSPTFDNN--GSMMFLDMSYNMLS-GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL-DGRIP  697 (768)
T ss_dssp             EECCCSCSSS--BCCCEEECCSSCCB-SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC-EECCC
T ss_pred             ccCchhhhcc--ccccEEECcCCccc-ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc-cCcCC
Confidence            5567777888  89999999999998 556677888888 99999999998 6777778899999999999999 44557


Q ss_pred             cccCccccccccccccccCcccCCCCCCCC
Q psy9363         390 NALGSLPNLKYLNLASTNLRNIKLNKEGHY  419 (421)
Q Consensus       390 ~~l~~l~~L~~L~Ls~N~l~~i~~p~~~~~  419 (421)
                      ..++.++.|+.|++++|++++ ++|..+.|
T Consensus       698 ~~l~~l~~L~~L~ls~N~l~g-~iP~~~~~  726 (768)
T 3rgz_A          698 QAMSALTMLTEIDLSNNNLSG-PIPEMGQF  726 (768)
T ss_dssp             GGGGGCCCCSEEECCSSEEEE-ECCSSSSG
T ss_pred             hHHhCCCCCCEEECcCCcccc-cCCCchhh
Confidence            788899999999999999988 77776554



>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2z0w_A CAP-Gly domain-containing linker protein 4; alternative splicing, ANK repeat, protein binding, structural genomics, NPPSFA; 2.50A {Homo sapiens} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>4b6m_A Tubulin-specific chaperone, putative; structural protein; 1.59A {Trypanosoma brucei} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>1lpl_A Hypothetical 25.4 kDa protein F53F4.3 in chromosome V; structural genomics, CAP-Gly domain, cytoskeleton, tubulin, PSI; 1.77A {Caenorhabditis elegans} SCOP: b.34.10.1 PDB: 1tov_A Back     alignment and structure
>2e3i_A Restin; CAP-Gly, cytoplasmic linker, tubulin binding, structural protein; 2.00A {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3rdv_A CAP-Gly domain-containing linker protein 1; cytoskeletal protein, CAP Gly protein complex, structural PR; HET: BME; 1.75A {Homo sapiens} PDB: 2qk0_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1ixd_A Cylindromatosis tumour-suppressor CYLD; structural genomics, riken structural genomics/proteomics initiative, RSGI, antitumor protein; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2e3h_A Restin; CAP-Gly, cytoplasmic linker, tubulin binding, structural protein; 1.45A {Homo sapiens} SCOP: b.34.10.1 PDB: 2e4h_A Back     alignment and structure
>2cp2_A CLIP-115, KIAA0291; microtubule binding, cytoskeleton associated protein, CYLN2, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 PDB: 2cp7_A Back     alignment and structure
>1whg_A Tubulin specific chaperone B; microtubule binding, cytoskeleton associated protein, ckapi, structural genomics; NMR {Mus musculus} SCOP: b.34.10.1 Back     alignment and structure
>2cp0_A Clipr-59 protein, clipr59; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2cp3_A CLIP-115, KIAA0291; microtubule binding, cytoskeleton associated protein, CYLN2, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>1whh_A Clipr-59; microtubule binding, trans-golgi network, structural genomics, riken structural genomics/proteomics initiative, RSGI, structural protein; NMR {Mus musculus} SCOP: b.34.10.1 Back     alignment and structure
>1whl_A Cylindromatosis tumor suppressor CYLD; deubiquitinating enzyme, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>1txq_A Dynactin 1; protein complex, structural protein/protein binding complex; 1.80A {Homo sapiens} SCOP: b.34.10.1 PDB: 2hqh_A 2hkq_B 2hkn_A 2pzo_A 3e2u_A 2hl5_C 2hl3_A 3tq7_P Back     alignment and structure
>1whk_A 1700024K14RIK, riken cDNA 1700024K14; structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.34.10.1 Back     alignment and structure
>1whj_A 1700024K14RIK, riken cDNA 1700024K14; structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.34.10.1 Back     alignment and structure
>2cp6_A Restin; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2coz_A CAP350, centrosome-associated protein 350; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2coy_A Dynactin-1; microtubule binding, cytoskeleton associated protein, P150- glued, DAP-150, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2cp5_A Restin; microtubule binding, cytoskeleton associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>2cow_A Kinesin-like protein KIF13B; microtubule binding, cytoskeleton associated protein, KIAA0639, kinesin-like protein gakin, structural genomics; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>1whm_A Cylindromatosis tumor suppressor CYLD; deubiquitinating enzyme, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.34.10.1 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 421
d1ixda_104 b.34.10.1 (A:) Cylindromatosis tumour-suppressor C 3e-20
d1whha_102 b.34.10.1 (A:) CLIP170-related 59kda protein CLIPR 6e-20
d2cp0a183 b.34.10.1 (A:7-89) CLIP170-related 59kda protein C 3e-19
d2e3ha171 b.34.10.1 (A:212-282) CLIP-115 {Human (Homo sapien 6e-19
d2cowa188 b.34.10.1 (A:7-94) Kinesin-like protein kif13b {Hu 1e-18
d2e3ia171 b.34.10.1 (A:58-128) Restin {Human (Homo sapiens) 2e-18
d1whja_102 b.34.10.1 (A:) Restin-like protein 2, Rsnl2 {Mouse 2e-18
d2coza1109 b.34.10.1 (A:8-116) Centrosome-associated protein 3e-18
d2cp6a1160 b.34.10.1 (A:8-167) Restin {Human (Homo sapiens) [ 1e-17
d1whka_91 b.34.10.1 (A:) Restin-like protein 2, Rsnl2 {Mouse 2e-17
d1tova_98 b.34.10.1 (A:) Cytoskeleton-associated protein F53 3e-17
d2hqha172 b.34.10.1 (A:26-97) Dynactin 1 {Human (Homo sapien 4e-17
d1whga_113 b.34.10.1 (A:) Tubulin-specific chaperone B (SKAP1 1e-16
d1whma_92 b.34.10.1 (A:) Cylindromatosis tumour-suppressor C 6e-16
d1whla_95 b.34.10.1 (A:) Cylindromatosis tumour-suppressor C 1e-15
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 8e-06
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 2e-04
d2omza2 384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 0.003
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 2e-05
d1h6ua2227 c.10.2.1 (A:36-262) Internalin H {Listeria monocyt 2e-04
d1xkua_ 305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 5e-04
d1h6ta2210 c.10.2.1 (A:31-240) Internalin B {Listeria monocyt 6e-04
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 0.001
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.003
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.004
d1p9ag_ 266 c.10.2.7 (G:) von Willebrand factor binding domain 0.004
>d1ixda_ b.34.10.1 (A:) Cylindromatosis tumour-suppressor Cyld {Human (Homo sapiens) [TaxId: 9606]} Length = 104 Back     information, alignment and structure

class: All beta proteins
fold: SH3-like barrel
superfamily: Cap-Gly domain
family: Cap-Gly domain
domain: Cylindromatosis tumour-suppressor Cyld
species: Human (Homo sapiens) [TaxId: 9606]
 Score = 83.4 bits (206), Expect = 3e-20
 Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 1/70 (1%)

Query: 188 RVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMR 247
            V ++    G IR++G   G   V  G++ + E  G  DG+  G +YF         F++
Sbjct: 25  EVKENPPFYGVIRWIGQPPGLNEVLAGLELEDECAGCTDGTFRGTRYFTCAL-KKALFVK 83

Query: 248 RDKLNFGSSF 257
                  S F
Sbjct: 84  LKSCRPDSRF 93


>d1whha_ b.34.10.1 (A:) CLIP170-related 59kda protein CLIPR-59 (1500005P14Rik) {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 Back     information, alignment and structure
>d2cp0a1 b.34.10.1 (A:7-89) CLIP170-related 59kda protein CLIPR-59 (1500005P14Rik) {Human (Homo sapiens) [TaxId: 9606]} Length = 83 Back     information, alignment and structure
>d2e3ha1 b.34.10.1 (A:212-282) CLIP-115 {Human (Homo sapiens) [TaxId: 9606]} Length = 71 Back     information, alignment and structure
>d2cowa1 b.34.10.1 (A:7-94) Kinesin-like protein kif13b {Human (Homo sapiens) [TaxId: 9606]} Length = 88 Back     information, alignment and structure
>d2e3ia1 b.34.10.1 (A:58-128) Restin {Human (Homo sapiens) [TaxId: 9606]} Length = 71 Back     information, alignment and structure
>d1whja_ b.34.10.1 (A:) Restin-like protein 2, Rsnl2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 Back     information, alignment and structure
>d2coza1 b.34.10.1 (A:8-116) Centrosome-associated protein 350 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 Back     information, alignment and structure
>d2cp6a1 b.34.10.1 (A:8-167) Restin {Human (Homo sapiens) [TaxId: 9606]} Length = 160 Back     information, alignment and structure
>d1whka_ b.34.10.1 (A:) Restin-like protein 2, Rsnl2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 91 Back     information, alignment and structure
>d1tova_ b.34.10.1 (A:) Cytoskeleton-associated protein F53F4.3 {Caenorhabditis elegans [TaxId: 6239]} Length = 98 Back     information, alignment and structure
>d2hqha1 b.34.10.1 (A:26-97) Dynactin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 72 Back     information, alignment and structure
>d1whga_ b.34.10.1 (A:) Tubulin-specific chaperone B (SKAP1) {Mouse (Mus musculus) [TaxId: 10090]} Length = 113 Back     information, alignment and structure
>d1whma_ b.34.10.1 (A:) Cylindromatosis tumour-suppressor Cyld {Human (Homo sapiens) [TaxId: 9606]} Length = 92 Back     information, alignment and structure
>d1whla_ b.34.10.1 (A:) Cylindromatosis tumour-suppressor Cyld {Human (Homo sapiens) [TaxId: 9606]} Length = 95 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query421
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.8
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.67
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.64
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.55
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.53
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.53
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.47
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.44
d2e3ia171 Restin {Human (Homo sapiens) [TaxId: 9606]} 99.43
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.42
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.4
d2hqha172 Dynactin 1 {Human (Homo sapiens) [TaxId: 9606]} 99.39
d2cp0a183 CLIP170-related 59kda protein CLIPR-59 (1500005P14 99.39
d2e3ha171 CLIP-115 {Human (Homo sapiens) [TaxId: 9606]} 99.37
d2cowa188 Kinesin-like protein kif13b {Human (Homo sapiens) 99.35
d1ixda_104 Cylindromatosis tumour-suppressor Cyld {Human (Hom 99.32
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.31
d2coza1109 Centrosome-associated protein 350 {Human (Homo sap 99.3
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.29
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.29
d1tova_98 Cytoskeleton-associated protein F53F4.3 {Caenorhab 99.28
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.27
d1whja_102 Restin-like protein 2, Rsnl2 {Mouse (Mus musculus) 99.27
d2cp6a1160 Restin {Human (Homo sapiens) [TaxId: 9606]} 99.26
d1whka_91 Restin-like protein 2, Rsnl2 {Mouse (Mus musculus) 99.26
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.24
d1whha_102 CLIP170-related 59kda protein CLIPR-59 (1500005P14 99.24
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.23
d1whga_113 Tubulin-specific chaperone B (SKAP1) {Mouse (Mus m 99.22
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.22
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.22
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.2
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.16
d1whma_92 Cylindromatosis tumour-suppressor Cyld {Human (Hom 99.16
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.09
d1whla_95 Cylindromatosis tumour-suppressor Cyld {Human (Hom 99.08
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.04
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.95
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.95
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.9
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 98.89
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 98.85
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.84
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 98.82
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.76
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.75
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 98.7
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.63
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.57
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.49
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 98.47
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.15
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.96
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 97.84
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 97.58
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.16
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 95.9
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.80  E-value=7.6e-21  Score=179.82  Aligned_cols=257  Identities=18%  Similarity=0.137  Sum_probs=177.4

Q ss_pred             CCcEEECCCCCCCChhhHHHHHhcCCCCceeec-c-cccCCCCCCcccccccccchhccccccCCcchhhHHHHHhhCCC
Q psy9363          21 FIEDLDLSRNLLASWFAVGEITCQLKHLRHLNL-R-IRLKSSSAPAHSYLAEVVFFVHLGRTLCDEDFVKEGSLLHYLPK   98 (421)
Q Consensus        21 ~L~~L~Ls~N~ls~~~~i~~~~~~l~~L~~L~L-~-N~l~~~~~p~~~~~~~~L~~L~L~~~~~~~~~~~~~~ll~~l~~   98 (421)
                      +++.|||++|.++....+|..+++|++|++|+| + |.+. +.+|..++.+++|++|+|++|.+.+.....   +..+++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~-g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~---~~~~~~  126 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV-GPIPPAIAKLTQLHYLYITHTNVSGAIPDF---LSQIKT  126 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEE-SCCCGGGGGCTTCSEEEEEEECCEEECCGG---GGGCTT
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccc-cccccccccccccchhhhcccccccccccc---ccchhh
Confidence            699999999999965578889999999999999 4 7888 689999999999999999988776654444   667999


Q ss_pred             CceeeecCCCCCCccccchhHHHHHHhccCceeccCCccChhhhhccHHHHHHhhccccchhhHHHHHHHhCCCCCCccc
Q psy9363          99 LSSLRFTKNPILAEERVVSSREKTIARLGGLKLLNGSAIERQERQGSEYDYIKEFGAVWLDEKRRAEFLEANPRVGDNYF  178 (421)
Q Consensus        99 L~~L~l~~N~l~~~~~~~~~~~~~i~~l~~L~~ln~s~i~~~~r~~ae~~~l~~~~~~~~~~~~~~~~~~~~~~~~~n~~  178 (421)
                      |+++++++|.+..      ..+..++.++.|+.++.+.....             +..+                  ..+
T Consensus       127 L~~l~l~~N~~~~------~~p~~l~~l~~L~~l~l~~n~l~-------------~~ip------------------~~~  169 (313)
T d1ogqa_         127 LVTLDFSYNALSG------TLPPSISSLPNLVGITFDGNRIS-------------GAIP------------------DSY  169 (313)
T ss_dssp             CCEEECCSSEEES------CCCGGGGGCTTCCEEECCSSCCE-------------EECC------------------GGG
T ss_pred             hcccccccccccc------cCchhhccCcccceeeccccccc-------------cccc------------------ccc
Confidence            9999999998743      34567889999998888632111             1111                  000


Q ss_pred             ccccCCCCceEEeecCceeEEEEecccCCCCCcEEEEEecCCCCCCCCCeeCCEEeEecCCCCceeEEecCccccCchhH
Q psy9363         179 QVMEDDIGLRVCDSEGHRGTIRYVGSVEGTQGVWYGIDWDSETRGKHDGSHNGVKYFWTHSTTSGSFMRRDKLNFGSSFM  258 (421)
Q Consensus       179 ~~~~~~i~~rv~~l~~~~~~~r~~G~ip~~~g~~~gle~d~~~~g~~~G~~~g~~~f~~~~~~~gsf~~~~~l~~g~~~~  258 (421)
                      ... ......+     ....+++.|..|...+...                                             
T Consensus       170 ~~l-~~l~~~l-----~~~~n~l~~~~~~~~~~l~---------------------------------------------  198 (313)
T d1ogqa_         170 GSF-SKLFTSM-----TISRNRLTGKIPPTFANLN---------------------------------------------  198 (313)
T ss_dssp             GCC-CTTCCEE-----ECCSSEEEEECCGGGGGCC---------------------------------------------
T ss_pred             ccc-ccccccc-----ccccccccccccccccccc---------------------------------------------
Confidence            000 0000000     1122222322221110000                                             


Q ss_pred             HHhhhhhccccchhhhccccceeeeeecCceeEeecccchhhhhCCCccCCCCCCCchhhhcCCCCCccEEEeeCcccch
Q psy9363         259 EALHRKYVETDNELTVRENVEEVKASINAPFLELVGFDQVHEEQNTNKLPIPNDTSGVMEQIFPQGHIHTLTLGNMGYIW  338 (421)
Q Consensus       259 ~al~~~y~~~~~~~~~~~~~~~~~~~~~~~~~e~~g~~~l~~~~~L~~l~l~~~~~~~~~~~l~~~~L~~L~Ls~N~l~~  338 (421)
                                           ...+.+.....+                    +.+|..+..+  ++++.+++++|.+. 
T Consensus       199 ---------------------~~~l~l~~~~~~--------------------~~~~~~~~~~--~~l~~l~~~~~~l~-  234 (313)
T d1ogqa_         199 ---------------------LAFVDLSRNMLE--------------------GDASVLFGSD--KNTQKIHLAKNSLA-  234 (313)
T ss_dssp             ---------------------CSEEECCSSEEE--------------------ECCGGGCCTT--SCCSEEECCSSEEC-
T ss_pred             ---------------------cccccccccccc--------------------cccccccccc--cccccccccccccc-
Confidence                                 000000010000                    4456677788  99999999999998 


Q ss_pred             hhHHHHhccCCC-cEEEccCCcCc-ccCCCCCCCCCCcEEECcCCCCCCCCcccccCcccccccccccccc-CcccCCCC
Q psy9363         339 ADILKLLANFPV-TCLKLPSNRIT-TLDSVPGMFSSLEELYLQENNIVDWGEVNALGSLPNLKYLNLASTN-LRNIKLNK  415 (421)
Q Consensus       339 ~~i~~~~~~l~~-~~L~L~~N~l~-~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~Ls~N~-l~~i~~p~  415 (421)
                      ..++ .+..+++ +.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ +. +..++.+++|+.+++++|+ +.+.|+|.
T Consensus       235 ~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~-g~-iP~~~~L~~L~~l~l~~N~~l~g~plp~  311 (313)
T d1ogqa_         235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-GE-IPQGGNLQRFDVSAYANNKCLCGSPLPA  311 (313)
T ss_dssp             CBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE-EE-CCCSTTGGGSCGGGTCSSSEEESTTSSC
T ss_pred             cccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc-cc-CCCcccCCCCCHHHhCCCccccCCCCCC
Confidence            2222 3566778 99999999999 68887899999999999999995 33 3467889999999999997 78878886


Q ss_pred             C
Q psy9363         416 E  416 (421)
Q Consensus       416 ~  416 (421)
                      +
T Consensus       312 c  312 (313)
T d1ogqa_         312 C  312 (313)
T ss_dssp             C
T ss_pred             C
Confidence            4



>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2e3ia1 b.34.10.1 (A:58-128) Restin {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2hqha1 b.34.10.1 (A:26-97) Dynactin 1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2cp0a1 b.34.10.1 (A:7-89) CLIP170-related 59kda protein CLIPR-59 (1500005P14Rik) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2e3ha1 b.34.10.1 (A:212-282) CLIP-115 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2cowa1 b.34.10.1 (A:7-94) Kinesin-like protein kif13b {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ixda_ b.34.10.1 (A:) Cylindromatosis tumour-suppressor Cyld {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2coza1 b.34.10.1 (A:8-116) Centrosome-associated protein 350 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1tova_ b.34.10.1 (A:) Cytoskeleton-associated protein F53F4.3 {Caenorhabditis elegans [TaxId: 6239]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1whja_ b.34.10.1 (A:) Restin-like protein 2, Rsnl2 {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d2cp6a1 b.34.10.1 (A:8-167) Restin {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1whka_ b.34.10.1 (A:) Restin-like protein 2, Rsnl2 {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1whha_ b.34.10.1 (A:) CLIP170-related 59kda protein CLIPR-59 (1500005P14Rik) {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1whga_ b.34.10.1 (A:) Tubulin-specific chaperone B (SKAP1) {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1whma_ b.34.10.1 (A:) Cylindromatosis tumour-suppressor Cyld {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1whla_ b.34.10.1 (A:) Cylindromatosis tumour-suppressor Cyld {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure